Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SCAN domain containing 3 pseudogene 1 (SCAND3P1) is a processed pseudogene in the human genome, related to the SCAND3 gene. Pseudogenes like SCAND3P1 arise from duplication or retrotransposition events leading to non-functional gene copies that usually do not encode active proteins. While some pseudogenes actively regulate gene expression by competing for microRNAs or through other non-coding RNA regulatory mechanisms, there is no current evidence that SCAND3P1 has such functions. No disease implications, therapeutic utility, or biomarker roles have been reported for SCAND3P1. It is classified simply as a pseudogene, distinguished from genes encoding receptors, enzymes, or other drug targets. SCAND3P1 is a non-coding pseudogene, not a therapeutic target, receptor, enzyme, transporter, or transcription factor. No known disease or drug interactions; no direct biological or clinical roles attributed based on current evidence. Its main significance is genomic annotation and possible utility as a marker of genomic organization or evolutionary biology, not clinical practice.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SCAN domain containing 3 pseudogene 1 (SCAND3P1).